1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Nielsen, J.T.
Bjerring, M.
Jeppesen, M.D.
Pedersen, R.O.
Pedersen, J.M.
Hein, K.L.
Vosegaard, T.
Skrydstrup, T.
Otzen, D.E.
Nielsen, N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
GE
Angew.Chem.Int.Ed.Engl.
9999
1433-7851
48
2118
2121
10.1002/anie.200804198
19130518
Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy.
2009
720.815
NFGAIL segment from human islet amyloid polypeptide
8
syn
polymer
no
no
NFGAILS
NFGAILS
A,B,C,D,E,F,G,H
polypeptide(L)
n
n
n
n
n
n
n
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
2009-09-08
1
1
2011-07-13
1
2
2020-02-26
_pdbx_database_status.status_code_cs
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
BMRB
Y
RCSB
2009-05-01
REL
REL
REL
structures with the lowest energy
1000
10
0.049
NCA
NCO
2D 13C-13C DARR 2.5 ms mixing
2D 13C-13C DARR 5 ms mixing
2D 13C-13C DARR 20 ms mixing
2D 13C-13C DARR 40 ms mixing
2D 13C-13C DARR 100 ms mixing
2D 13C-13C DARR 200 ms mixing
2.5
mg/mL
[U-100% 13C; U-100% 15N]
7.2
ambient
263
K
torsion angle dynamics
1
lowest energy
2.5 mg/mL [U-100% 13C; U-100% 15N] NFGAIL, 100% H2O
100% H2O
Schwieters, C.D. et al.
refinement
X-PLOR NIH
2.18
700
Bruker
AVANCE
Bruker Avance
ASN
1
n
1
ASN
1
A
PHE
2
n
2
PHE
2
A
GLY
3
n
3
GLY
3
A
ALA
4
n
4
ALA
4
A
ILE
5
n
5
ILE
5
A
LEU
6
n
6
LEU
6
A
SER
7
n
7
SER
7
A
ASN
1
n
1
ASN
1
B
PHE
2
n
2
PHE
2
B
GLY
3
n
3
GLY
3
B
ALA
4
n
4
ALA
4
B
ILE
5
n
5
ILE
5
B
LEU
6
n
6
LEU
6
B
SER
7
n
7
SER
7
B
ASN
1
n
1
ASN
1
C
PHE
2
n
2
PHE
2
C
GLY
3
n
3
GLY
3
C
ALA
4
n
4
ALA
4
C
ILE
5
n
5
ILE
5
C
LEU
6
n
6
LEU
6
C
SER
7
n
7
SER
7
C
ASN
1
n
1
ASN
1
D
PHE
2
n
2
PHE
2
D
GLY
3
n
3
GLY
3
D
ALA
4
n
4
ALA
4
D
ILE
5
n
5
ILE
5
D
LEU
6
n
6
LEU
6
D
SER
7
n
7
SER
7
D
ASN
1
n
1
ASN
1
E
PHE
2
n
2
PHE
2
E
GLY
3
n
3
GLY
3
E
ALA
4
n
4
ALA
4
E
ILE
5
n
5
ILE
5
E
LEU
6
n
6
LEU
6
E
SER
7
n
7
SER
7
E
ASN
1
n
1
ASN
1
F
PHE
2
n
2
PHE
2
F
GLY
3
n
3
GLY
3
F
ALA
4
n
4
ALA
4
F
ILE
5
n
5
ILE
5
F
LEU
6
n
6
LEU
6
F
SER
7
n
7
SER
7
F
ASN
1
n
1
ASN
1
G
PHE
2
n
2
PHE
2
G
GLY
3
n
3
GLY
3
G
ALA
4
n
4
ALA
4
G
ILE
5
n
5
ILE
5
G
LEU
6
n
6
LEU
6
G
SER
7
n
7
SER
7
G
ASN
1
n
1
ASN
1
H
PHE
2
n
2
PHE
2
H
GLY
3
n
3
GLY
3
H
ALA
4
n
4
ALA
4
H
ILE
5
n
5
ILE
5
H
LEU
6
n
6
LEU
6
H
SER
7
n
7
SER
7
H
author_defined_assembly
8
octameric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
C
O
PHE
2
C
O
PHE
2
A
N
LEU
6
A
N
LEU
6
A
N
ILE
5
A
N
ILE
5
E
O
GLY
3
E
O
GLY
3
E
N
PHE
2
E
N
PHE
2
G
O
LEU
6
G
O
LEU
6
D
O
PHE
2
D
O
PHE
2
B
N
LEU
6
B
N
LEU
6
B
N
ILE
5
B
N
ILE
5
F
O
GLY
3
F
O
GLY
3
F
N
PHE
2
F
N
PHE
2
H
O
LEU
6
H
O
LEU
6
NFGAIL segment from human islet amyloid polypeptide
Protein Fibril
1
N
N
1
N
N
1
N
N
1
N
N
1
N
N
1
N
N
1
N
N
1
N
N
PROTEIN FIBRIL
Protein fibril, IAPP, Amylin, SNNFGAILSS, Symmetry
2KIB
PDB
1
2KIB
1
7
2KIB
1
7
2KIB
A
1
1
7
1
7
2KIB
1
7
2KIB
B
1
1
7
1
7
2KIB
1
7
2KIB
C
1
1
7
1
7
2KIB
1
7
2KIB
D
1
1
7
1
7
2KIB
1
7
2KIB
E
1
1
7
1
7
2KIB
1
7
2KIB
F
1
1
7
1
7
2KIB
1
7
2KIB
G
1
1
7
1
7
2KIB
1
7
2KIB
H
1
1
7
4
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
C
PHE
2
C
PHE
2
C
LEU
6
C
LEU
6
A
PHE
2
A
PHE
2
A
LEU
6
A
LEU
6
E
PHE
2
E
PHE
2
E
LEU
6
E
LEU
6
G
PHE
2
G
PHE
2
G
LEU
6
G
LEU
6
D
PHE
2
D
PHE
2
D
LEU
6
D
LEU
6
B
PHE
2
B
PHE
2
B
LEU
6
B
LEU
6
F
PHE
2
F
PHE
2
F
LEU
6
F
LEU
6
H
PHE
2
H
PHE
2
H
LEU
6
H
LEU
6